Linked Life Data

19526878

Source:http://linkedlifedata.com/resource/pubmed/id/19526878

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-6-16
pubmed:abstractText
Tadenan, a drug of plant origin, was given to 27 patients with documented prostatic adenoma for 3-12 months. Home uroflowmonitoring for 1, 3, 6 and 12 months registered positive changes in urinary flow rate and urination volume. Side effects were absent. IPSS and QoL parameters were also assessed.
pubmed:language
rus
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1728-2985
pubmed:author
pubmed:issnType
Print
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
68, 70-3
pubmed:meshHeading
pubmed:articleTitle
[Tadenan treatment of prostatic adenoma].
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract